AFP and hepatocellular carcinoma: As showed in Table 6, compared with HBV‐HCC patients with 0 risk genotype, those with 1–2 risk genotypes had a significantly poorer OS in the subgroup with age ≤ 47, male, never smoking, never/ever drinking, AFP > 400, cancer embolus and BCLC B/C stage.